Device Trial Radar · NCT05757505
The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis
Last checked: Nov 20, 2026Latest source record: Jan 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
May 11, 2023
Primary completion
Jan 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Ton-Bridge Medical Tech. Co., LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 7, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to verify the efficacy and safety of the Intracranial Stent (Tonbridge) in endovascular treatment of symptomatic intracranial atherosclerotic stenosis.
Conditions
- Intracranial Atherosclerosis
Interventions
Intracranial Stent (Tonbridge)Device
Endovascular treatment with Intracranial Stent (Tonbridge).
Wingspan Stent System (Stryker Neurovascular)Device
Endovascular treatment with Wingspan Stent System (Stryker Neurovascular).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of any stroke and death within 30 daysTime frame: 30±7 days post-procedure
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Changhai Hospital of Shanghai
Shanghai, China · Not yet recruiting
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.